Company intelligence / Profile preview

REVA Medical

San Diego, California, United Statesrevamedical.com ↗

Ownership: Private
Employees: ~40
Development stage: Other

Overview

REVA’s Fantom Encore scaffold demonstrated successful deployment and resorption in coronary arteries with CE Mark approval in Europe. The MOTIV peripheral vascular scaffold showed 99% device success and 90% vessel patency at six months in a recent study of patients with severe peripheral arterial disease symptoms. TyroSphere beads are under development for tumor embolization.

Therapeutic areas: OncologyCardiovascular
Modalities: DevicePolymer-drug conjugate therapy (for drug-eluting scaffolds)Nanoparticle (for embolic beads)
Industry: Implantable Medical Devices

Partnerships

Boston Scientific held an exclusive option for global distribution of certain products historicallyMedtronic participated as an investor but no current commercial partnership disclosed

Beyond the preview

Go deeper on REVA Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on REVA Medical.

Explore the full profile